Home Cart 0 Sign in  

[ CAS No. 163706-61-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 163706-61-4
Chemical Structure| 163706-61-4
Structure of 163706-61-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 163706-61-4 ]

Related Doc. of [ 163706-61-4 ]

Alternatived Products of [ 163706-61-4 ]

Product Details of [ 163706-61-4 ]

CAS No. :163706-61-4 MDL No. :MFCD29916812
Formula : C13H31Cl2NO6P2 Boiling Point : -
Linear Structure Formula :- InChI Key :NDWFZUQKBXXXGW-UHFFFAOYSA-N
M.W : 430.24 Pubchem ID :9932400
Synonyms :

Calculated chemistry of [ 163706-61-4 ]

Physicochemical Properties

Num. heavy atoms : 24
Num. arom. heavy atoms : 0
Fraction Csp3 : 1.0
Num. rotatable bonds : 11
Num. H-bond acceptors : 7.0
Num. H-bond donors : 4.0
Molar Refractivity : 101.22
TPSA : 137.92 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -9.16 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.21
Log Po/w (XLOGP3) : -0.33
Log Po/w (WLOGP) : 4.12
Log Po/w (MLOGP) : 1.29
Log Po/w (SILICOS-IT) : 3.28
Consensus Log Po/w : 2.11

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 1.0
Egan : 1.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.57
Solubility : 11.5 mg/ml ; 0.0267 mol/l
Class : Very soluble
Log S (Ali) : -2.11
Solubility : 3.38 mg/ml ; 0.00785 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.02
Solubility : 0.0409 mg/ml ; 0.0000951 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 4.18

Safety of [ 163706-61-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 163706-61-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 163706-61-4 ]

[ 163706-61-4 ] Synthesis Path-Downstream   1~1

  • 1
  • [ 1802999-55-8 ]
  • [ 163706-61-4 ]
  • [ CAS Unavailable ]
YieldReaction ConditionsOperation in experiment
28% Stage #1: C20H24N2O9S; dichloromethylenebisphosphonic acid bis(tri-n-butylammonium) salt In N,N-dimethyl-formamide at 70℃; for 72h; Stage #2: With acetic acid In water at 95℃; Stage #3: In water 6 Typical procedure for the preparation of uridine nucleoside 5'-diphosphate derivatives, 6-18, 23 General procedure: To a suspension of uridine derivatives (0.1 mmol, 1 eq) (33-37, 39 and 41) the appropriate diphosphonatebis(tributylammonium) salt (0.2 mmol, 2 eq) dissolved in dry DMF (0.5 mL) was added: bis(tetrabutylammonium)methylene diphosphonate for 6, 9, 12, 16-18 and 23,bis(tributylammonium)dichloromethylene diphosphonate for 7, 10 and 13 and bis(tributylammonium)difluoromethylene diphosphonate for 8, 11 and 14.The resulting solution was stirred at 70 °C for 3 days. The mixture was cooled to RT and water (5 mL) was added and stirred at RT for 20 min. The solvent was freeze-dried and the crude residue dissolved in a mixture of acetic acid (2 mL) and water (0.5 mL) and stirred for 90 min at 95 °C. 24% NH4OH solution was added to neutralize the reaction mixture which was then freeze-dried. The semisolid obtained was chromatographed on an activated Sephadex DEAE-A25 column. The resin was washed with deionized water and loaded with the crude reaction residue dissolved in a minimal volume of water. The separation was monitored by UV detection at 280 nm. A buffer gradient of 800 mL water to 800 mL 0.5 M NH4HCO3 was used.The relevant fractions were pooled and freeze-dried three times to yield a white solid. Final purification was carried out by HPLC, using a semipreparative reverse-phase column. The purity of the nucleotides was evaluated on an analytical reverse-phase column system in two solvent systems (see below). The products, obtained as triethylammonium salts, were generally>95% pure. Finally, the products (dissolved in water) were passed through a CM Sephadex sodium-form ion-exchange resin column and eluted with deionized water to obtain the corresponding sodium salts after freeze-drying.
Same Skeleton Products
Historical Records